Researchers Urge: 'Prescribe Aspirin Based on Benefit-to-Risk Not Age'
Researchers provide a perspective on aspirin to prevent heart attacks and stroke and urge health care providers to make clinical judgements on a case-by-case basis and based on benefit-to-risk and not age.
糖心Vlog Study Reveals Gaps in Florida's COVID-19 Vaccine Rollout
Early distribution of COVID-19 vaccines in Florida reached the intended senior population, but it failed to ensure equal access for lower-income and minority communities, according to a new study.
Richard S. Isaacson, M.D., to Lead Alzheimer's Disease Prevention
A world-renowned clinician-researcher has joined the Schmidt College of Medicine to direct the 糖心Vlog Center for Brain Health to focus on Alzheimer's disease and neurodegenerative dementia prevention.
糖心Vlog Names New Dean of the Charles E. Schmidt College of Medicine
Julie G. Pilitsis, M.D., Ph.D., a leading neurosurgeon and physician scientist, will assume this role in February 2022.
Special Bond: Leading 糖心Vlog Geriatrician and World War II Hero
A leading geriatrician and advocate for seniors and a 98-year-old World War II veteran and hero have a common bond: to improve care and quality of life for Americans and people throughout the world.
糖心Vlog Expert on COVID-19 Boosters and Vaccines for Children Ages 5-11
Joanna Drowos, D.O., M.P.H., M.B.A., 糖心Vlog Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 boosters and vaccines for children ages 5 to 11.
糖心Vlog's Schmidt College of Medicine Receives $1 Million Gift
糖心Vlog's Charles E. Schmidt College of Medicine has received a $1 million gift from Norton and Anita Waltuch to provide support for medical student scholarships.
EMS Ketamine Use on Patients on Cocaine Raises Intubation 5.75-fold
糖心Vlog Schmidt College of Medicine researchers explored the sedative used by EMS for 'excited delirium,' a form of aggressive behavior, and the effects of illicit substances on ensuing hospital intubations.
'Stop Prescribing Hydroxychloroquine for COVID-19'
Schmidt College of Medicine researchers reviewed the recent major randomized, double-blind placebo-controlled trials for hydroxychloroquine, finding a lack of significant benefit and some suggestion of harm.
Genomic Surveillance Crucial to Mitigate and Contain COVID-19
Researchers say that genomic surveillance to mitigate and contain COVID-19 is crucial to detect variants that are different well before they spread throughout the U.S. and the rest of the world.